The Europe Transdermal Drug Delivery Systems Market would witness market growth of 4.2% CAGR during the forecast period (2022-2028).
Modern drug delivery systems have been improved because of developments in materials research and bionanotechnology, which should speed the development of personalized medicine. Despite the fact that topically applied dermatological pharmaceutical formulations like gels, lotions, foams, creams, etc. have been suggested for years, these systems primarily focus on disorders of the skin. TDDS are particularly tempting for treating both systemic medical diseases as well as local difficulties such as muscle or joint concerns.
In addition to being painless and non-invasive, TDDSs are well suited to minimize repeated administrations in order to maintain consistent drug delivery. They can also deliver medications with a short half-life period more efficiently. In TDDS, evaluating delivery efficacy and efficiency is a crucial procedure. Depending on the kind of medicine being given and its intended application, several approaches are used.
The three most popular techniques entail the employment of tape stripping, diffusion cells, microscopic, and spectroscopic inspection, each of which employs a different technique for data interpretation. All the characterization techniques are based on the idea of monitoring the drug dosage in surface layer as it is absorbed or of retaining an imaging substance in lieu of the drug to visually verify the absorption behavior.
Germany is the biggest market in Europe for TDDS, and its expansion is largely attributable to rising R&D expenditures for the creation of novel drug delivery systems. Transdermal patches and transdermal semisolids are the two of most sellable TDDS products in the region. The region experiences a rise in mortality caused by coronary diseases, which have been on the rise due to changes brought on by hectic lifestyles and less care for health. This has promoted the use of transdermal medications and thus, expedites the development of the transdermal drug delivery systems market in the region.
The Germany market dominated the Europe Transdermal Drug Delivery Systems Market by Country in 2021; thereby, achieving a market value of $4,708.6 million by 2028. The UK market is exhibiting a CAGR of 3.3% during (2022 - 2028). Additionally, The France market would showcase a CAGR of 5% during (2022 - 2028).
Based on Application, the market is segmented into Analgesics, Hormone Replacement Therapies, Hypertension, Motion Sickness, Smoking Cessation and Others. Based on Type of Delivery System, the market is segmented into Passive and Active. Based on countries, the market is segmented into Germany, UK, France, Russia, Spain, Italy, and Rest of Europe.
Free Valuable Insights: The Global Transdermal Drug Delivery Systems Market will Hit $72.4 Billion by 2028, at a CAGR of 4.6%
The market research report covers the analysis of key stake holders of the market. Key companies profiled in the report include Viatris Inc., Bayer AG, Boehringer Ingelheim GmbH, Endo International plc, GlaxoSmithKline plc, Johnson & Johnson, Novartis AG, Purdue Pharma L.P., Altaris and Hisamitsu Pharmaceutical Co. Inc.
Scope of the Study
Market Segments Covered in the Report:
By Application
- Analgesics
- Hormone Replacement Therapies
- Hypertension
- Motion Sickness
- Smoking Cessation
- Others
By Type of Delivery System
By Country
- Germany
- UK
- France
- Russia
- Spain
- Italy
- Rest of Europe
Key Market Players
List of Companies Profiled in the Report:
- Viatris Inc.
- Bayer AG
- Boehringer Ingelheim GmbH
- Endo International plc
- GlaxoSmithKline plc
- Johnson & Johnson
- Novartis AG
- Purdue Pharma L.P.
- Altaris
- Hisamitsu Pharmaceutical Co. Inc.
Chapter 1. Market Scope & Methodology
1.1 Market Definition
1.2 Objectives
1.3 Market Scope
1.4 Segmentation
1.4.1 Europe Transdermal Drug Delivery Systems Market, by Application
1.4.2 Europe Transdermal Drug Delivery Systems Market, by Type of Delivery System
1.4.3 Europe Transdermal Drug Delivery Systems Market, by Country
1.5 Methodology for the research
Chapter 2. Market Overview
2.1 Introduction
2.1.1 Overview
2.1.1.1 Market Composition and Scenario
2.2 Key Factors Impacting the Market
2.2.1 Market Drivers
2.2.2 Market Restraints
Chapter 3. Europe Transdermal Drug Delivery Systems Market by Application
3.1 Europe Analgesics Market by Country
3.2 Europe Hormone Replacement Therapies Market by Country
3.3 Europe Hypertension Market by Country
3.4 Europe Motion Sickness Market by Country
3.5 Europe Smoking Cessation Market by Country
3.6 Europe Others Market by Country
Chapter 4. Europe Transdermal Drug Delivery Systems Market by Type of Delivery System
4.1 Europe Passive Market by Country
4.2 Europe Active Market by Country
Chapter 5. Europe Transdermal Drug Delivery Systems Market by Country
5.1 Germany Transdermal Drug Delivery Systems Market
5.1.1 Germany Transdermal Drug Delivery Systems Market by Application
5.1.2 Germany Transdermal Drug Delivery Systems Market by Type of Delivery System
5.2 UK Transdermal Drug Delivery Systems Market
5.2.1 UK Transdermal Drug Delivery Systems Market by Application
5.2.2 UK Transdermal Drug Delivery Systems Market by Type of Delivery System
5.3 France Transdermal Drug Delivery Systems Market
5.3.1 France Transdermal Drug Delivery Systems Market by Application
5.3.2 France Transdermal Drug Delivery Systems Market by Type of Delivery System
5.4 Russia Transdermal Drug Delivery Systems Market
5.4.1 Russia Transdermal Drug Delivery Systems Market by Application
5.4.2 Russia Transdermal Drug Delivery Systems Market by Type of Delivery System
5.5 Spain Transdermal Drug Delivery Systems Market
5.5.1 Spain Transdermal Drug Delivery Systems Market by Application
5.5.2 Spain Transdermal Drug Delivery Systems Market by Type of Delivery System
5.6 Italy Transdermal Drug Delivery Systems Market
5.6.1 Italy Transdermal Drug Delivery Systems Market by Application
5.6.2 Italy Transdermal Drug Delivery Systems Market by Type of Delivery System
5.7 Rest of Europe Transdermal Drug Delivery Systems Market
5.7.1 Rest of Europe Transdermal Drug Delivery Systems Market by Application
5.7.2 Rest of Europe Transdermal Drug Delivery Systems Market by Type of Delivery System
Chapter 6. Company Profiles
6.1 Viatris, Inc.
6.1.1 Company Overview
6.1.2 Financial Analysis
6.1.3 Segmental and Regional Analysis
6.1.4 Research & Development Expense
6.1.5 Recent strategies and developments:
6.1.5.1 Approval:
6.2 Purdue Pharma L.P.
6.2.1 Company Overview
6.3 Bayer AG
6.3.1 Company Overview
6.3.2 Financial Analysis
6.3.3 Segmental and Regional Analysis
6.3.4 Research & Development Expense
6.4 Novartis AG
6.4.1 Company Overview
6.4.2 Financial Analysis
6.4.3 Segmental and Regional Analysis
6.4.4 Research & Development Expense
6.5 Boehringer Ingelheim International Gmbh
6.5.1 Company Overview
6.5.2 Financial Analysis
6.5.3 Regional & Segmental Analysis
6.5.4 Research & Development Expenses
6.6 GlaxoSmithKline PLC
6.6.1 Company Overview
6.6.2 Financial Analysis
6.6.3 Segmental and Regional Analysis
6.6.4 Research & Development Expense
6.7 Johnson & Johnson
6.7.1 Company Overview
6.7.2 Financial Analysis
6.7.3 Segmental &Regional Analysis
6.7.4 Research & Development Expenses
6.8 Endo International PLC
6.8.1 Company Overview
6.8.2 Financial Analysis
6.8.3 Segmental and Regional Analysis
6.8.4 Research & Development Expense
6.9 Altaris Capital Partners, LLC
6.9.1 Company Overview
6.9.2 Recent strategies and developments:
6.9.2.1 Acquisition and Mergers:
6.10. Hisamitsu Pharmaceutical Co. Inc.
6.10.1 Company Overview
6.10.2 Financial Analysis
6.10.3 Recent strategies and developments:
6.10.3.1 Approval:
TABLE 1 Europe Transdermal Drug Delivery Systems Market, 2018 - 2021, USD Million
TABLE 2 Europe Transdermal Drug Delivery Systems Market, 2022 - 2028, USD Million
TABLE 3 Europe Transdermal Drug Delivery Systems Market by Application, 2018 - 2021, USD Million
TABLE 4 Europe Transdermal Drug Delivery Systems Market by Application, 2022 - 2028, USD Million
TABLE 5 Europe Analgesics Market by Country, 2018 - 2021, USD Million
TABLE 6 Europe Analgesics Market by Country, 2022 - 2028, USD Million
TABLE 7 Europe Hormone Replacement Therapies Market by Country, 2018 - 2021, USD Million
TABLE 8 Europe Hormone Replacement Therapies Market by Country, 2022 - 2028, USD Million
TABLE 9 Europe Hypertension Market by Country, 2018 - 2021, USD Million
TABLE 10 Europe Hypertension Market by Country, 2022 - 2028, USD Million
TABLE 11 Europe Motion Sickness Market by Country, 2018 - 2021, USD Million
TABLE 12 Europe Motion Sickness Market by Country, 2022 - 2028, USD Million
TABLE 13 Europe Smoking Cessation Market by Country, 2018 - 2021, USD Million
TABLE 14 Europe Smoking Cessation Market by Country, 2022 - 2028, USD Million
TABLE 15 Europe Others Market by Country, 2018 - 2021, USD Million
TABLE 16 Europe Others Market by Country, 2022 - 2028, USD Million
TABLE 17 Europe Transdermal Drug Delivery Systems Market by Type of Delivery System, 2018 - 2021, USD Million
TABLE 18 Europe Transdermal Drug Delivery Systems Market by Type of Delivery System, 2022 - 2028, USD Million
TABLE 19 Europe Passive Market by Country, 2018 - 2021, USD Million
TABLE 20 Europe Passive Market by Country, 2022 - 2028, USD Million
TABLE 21 Europe Active Market by Country, 2018 - 2021, USD Million
TABLE 22 Europe Active Market by Country, 2022 - 2028, USD Million
TABLE 23 Europe Transdermal Drug Delivery Systems Market by Country, 2018 - 2021, USD Million
TABLE 24 Europe Transdermal Drug Delivery Systems Market by Country, 2022 - 2028, USD Million
TABLE 25 Germany Transdermal Drug Delivery Systems Market, 2018 - 2021, USD Million
TABLE 26 Germany Transdermal Drug Delivery Systems Market, 2022 - 2028, USD Million
TABLE 27 Germany Transdermal Drug Delivery Systems Market by Application, 2018 - 2021, USD Million
TABLE 28 Germany Transdermal Drug Delivery Systems Market by Application, 2022 - 2028, USD Million
TABLE 29 Germany Transdermal Drug Delivery Systems Market by Type of Delivery System, 2018 - 2021, USD Million
TABLE 30 Germany Transdermal Drug Delivery Systems Market by Type of Delivery System, 2022 - 2028, USD Million
TABLE 31 UK Transdermal Drug Delivery Systems Market, 2018 - 2021, USD Million
TABLE 32 UK Transdermal Drug Delivery Systems Market, 2022 - 2028, USD Million
TABLE 33 UK Transdermal Drug Delivery Systems Market by Application, 2018 - 2021, USD Million
TABLE 34 UK Transdermal Drug Delivery Systems Market by Application, 2022 - 2028, USD Million
TABLE 35 UK Transdermal Drug Delivery Systems Market by Type of Delivery System, 2018 - 2021, USD Million
TABLE 36 UK Transdermal Drug Delivery Systems Market by Type of Delivery System, 2022 - 2028, USD Million
TABLE 37 France Transdermal Drug Delivery Systems Market, 2018 - 2021, USD Million
TABLE 38 France Transdermal Drug Delivery Systems Market, 2022 - 2028, USD Million
TABLE 39 France Transdermal Drug Delivery Systems Market by Application, 2018 - 2021, USD Million
TABLE 40 France Transdermal Drug Delivery Systems Market by Application, 2022 - 2028, USD Million
TABLE 41 France Transdermal Drug Delivery Systems Market by Type of Delivery System, 2018 - 2021, USD Million
TABLE 42 France Transdermal Drug Delivery Systems Market by Type of Delivery System, 2022 - 2028, USD Million
TABLE 43 Russia Transdermal Drug Delivery Systems Market, 2018 - 2021, USD Million
TABLE 44 Russia Transdermal Drug Delivery Systems Market, 2022 - 2028, USD Million
TABLE 45 Russia Transdermal Drug Delivery Systems Market by Application, 2018 - 2021, USD Million
TABLE 46 Russia Transdermal Drug Delivery Systems Market by Application, 2022 - 2028, USD Million
TABLE 47 Russia Transdermal Drug Delivery Systems Market by Type of Delivery System, 2018 - 2021, USD Million
TABLE 48 Russia Transdermal Drug Delivery Systems Market by Type of Delivery System, 2022 - 2028, USD Million
TABLE 49 Spain Transdermal Drug Delivery Systems Market, 2018 - 2021, USD Million
TABLE 50 Spain Transdermal Drug Delivery Systems Market, 2022 - 2028, USD Million
TABLE 51 Spain Transdermal Drug Delivery Systems Market by Application, 2018 - 2021, USD Million
TABLE 52 Spain Transdermal Drug Delivery Systems Market by Application, 2022 - 2028, USD Million
TABLE 53 Spain Transdermal Drug Delivery Systems Market by Type of Delivery System, 2018 - 2021, USD Million
TABLE 54 Spain Transdermal Drug Delivery Systems Market by Type of Delivery System, 2022 - 2028, USD Million
TABLE 55 Italy Transdermal Drug Delivery Systems Market, 2018 - 2021, USD Million
TABLE 56 Italy Transdermal Drug Delivery Systems Market, 2022 - 2028, USD Million
TABLE 57 Italy Transdermal Drug Delivery Systems Market by Application, 2018 - 2021, USD Million
TABLE 58 Italy Transdermal Drug Delivery Systems Market by Application, 2022 - 2028, USD Million
TABLE 59 Italy Transdermal Drug Delivery Systems Market by Type of Delivery System, 2018 - 2021, USD Million
TABLE 60 Italy Transdermal Drug Delivery Systems Market by Type of Delivery System, 2022 - 2028, USD Million
TABLE 61 Rest of Europe Transdermal Drug Delivery Systems Market, 2018 - 2021, USD Million
TABLE 62 Rest of Europe Transdermal Drug Delivery Systems Market, 2022 - 2028, USD Million
TABLE 63 Rest of Europe Transdermal Drug Delivery Systems Market by Application, 2018 - 2021, USD Million
TABLE 64 Rest of Europe Transdermal Drug Delivery Systems Market by Application, 2022 - 2028, USD Million
TABLE 65 Rest of Europe Transdermal Drug Delivery Systems Market by Type of Delivery System, 2018 - 2021, USD Million
TABLE 66 Rest of Europe Transdermal Drug Delivery Systems Market by Type of Delivery System, 2022 - 2028, USD Million
TABLE 67 key information – Viatris, Inc.
TABLE 68 Key Information – Purdue Pharma L.P.
TABLE 69 Key Information – Bayer AG
TABLE 70 Key Information – Novartis AG
TABLE 71 Key Information – Boehringer Ingelheim International GmbH
TABLE 72 Key Information – GlaxoSmithKline PLC
TABLE 73 Key information – Johnson & Johnson
TABLE 74 Key Information – Endo International PLC
TABLE 75 Key Information – Altaris Capital Partners, LLC
TABLE 76 Key Information – Hisamitsu Pharmaceutical Co. Inc.
List of Figures
FIG 1 Methodology for the research